Quick Takeaways
- TCG Crossover GP I, LLC filed SCHEDULE 13G/A for Abivax SA Ordinary Shares, par value Euro 0.01 per share (ABVX).
- Disclosed ownership: 9.1%.
- Date of event: 30 Sep 2025.
TCG Crossover GP I, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Abivax SA Ordinary Shares, par value Euro 0.01 per share (ABVX)
- Filing Manager
- TCG Crossover GP I, LLC
- Reporting Manager
- Chen Yu
- Symbol
- ABVX
- Shares outstanding
- 78,149,407 shares
- Disclosed Ownership
- 7,111,596 shares
- Ownership
- 9.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:22:54 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"TCG Crossover GP I, LLC disclosed 9.1% ownership in Abivax SA Ordinary Shares, par value Euro 0.01 per share (ABVX) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 16:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP I, LLC | 8.3% | 6,456,596 | 0 | 6,456,596 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover Fund I, L.P. | 8.3% | 6,456,596 | 0 | 6,456,596 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover GP II, LLC | 0.8% | 655,000 | 0 | 655,000 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover Fund II, L.P. | 0.8% | 655,000 | 0 | 655,000 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| Chen Yu | 9.1% | 7,111,596 | 0 | 7,111,596 | /s/ Craig Skaling | Craig Skaling, as Attorney-in-Fact for Chen Yu |